Everspin Technologies, Inc. (MRAM)

Everspin Technologies (MRAM) is trading near the bottom of its 52-week range after a steep slide, with the stock at $12.71 and the 52-week range running from $7.35 to $51.50. Analysts remain strongly positive, with all four covering firms rating the stock Buy or Strong Buy, while CleaRank's own rating is Hold at 47/100.

That is 22.7 percentage points faster than the typical semiconductor company. Profitability has not caught up: the net profit margin is -14.28% and the operating margin is -38.40%. Return on equity is -14.78%, below the sector median of 13.4%. The balance sheet is light, with a debt-to-equity ratio of 0.04, so the losses are not a debt problem.

The October 28, 2026 report showed EPS of $0.12, matching the analysts' estimate exactly, and the stock fell 1.50% in the next session. Across the last eight reports, the company beat the EPS estimate four times, and three of those beats were followed by a lower share price in the first session. The August 5, 2026 beat of $0.11 against $0.09 was followed by a 3.04% drop. The April 29, 2026 beat was followed by a 38.59% jump, the largest move in that record, so a beat has not reliably lifted the shares. The pattern suggests that the market is focused on forward growth and margins rather than the quarter's headline EPS.

At a price-to-sales ratio of 4.49, the stock trades 40.9% below the sector median of 7.6. The market value is $310.4M. Against that discount, the trend is strongly negative. The price is 16.81% below its 50-day SMA and 23.93% below its 200-day SMA, and the 50-day SMA is 8.56% below the 200-day SMA. The MACD line is negative and the 14-day RSI of 43.7 is in the neutral zone. Over one month the stock is down 22.74%, and over one year it is up 35.50%.

Insiders sold $20.2M of stock over the last 18 months in 28 sales and made no open-market purchases. Such sales are often planned in advance or made to cover tax on vesting shares, so they carry less weight than purchases would. On the analyst side, Maxim Group started coverage at Buy on October 12, 2026, and Needham kept its Buy rating on August 6, 2026. All four analysts with a current rating rate the stock Buy or Strong Buy, and none rate it Hold or Sell. Three months ago, all three ratings were Buy.

The base case is that the stock stays volatile and trades in a range set by its moving averages until earnings growth shows up in profit. The stock has a typical daily move of 5.91% and a beta of 2.19, so swings of this size are normal for it. The main test is whether the price can reclaim the 20-day EMA at $13.48 and then the 50-day SMA at $15.28. If it does, the analysts' median target of $22.50 becomes the next reference point. If the shares fall through the recent low of $7.35, the trend weakens further and the bullish analyst view would be tested. Analysts expect revenue to rise 37.3% this fiscal year and EPS to reach $0.48, which is the operating base for the recovery case. Losses remain, with a GAAP EPS of -$0.41 and an operating margin of -38.40%, so profit is the missing piece.

Support sits at the 52-week low of $7.35, the nearest floor below the price. A break there would mark a new low for the year. Resistance starts at the 20-day EMA of $13.48, the level a rebound would meet first. Above it is the 50-day SMA at $15.28, which the price has not recovered, and then the 200-day SMA at $16.71. The 52-week high of $51.50 is the far ceiling and would require a very large rally.